A mechanism for upregulated ST6Gal-I expression in ovarian cancer has recently been suggested whereby SOX2 and ST6GAL1 are coordinately amplified in cancer cells, with the Sox2 protein then binding the ST6GAL1 promoter to further augment ST6Gal-I expression [180]. This evidence concerns the gene SOX2 and ovarian carcinoma.